
A federal judge heard arguments Monday on whether Oregon’s psilocybin program must accommodate people with disabilities who cannot travel to a licensed service center. U.S. District Judge Mustafa T. Kasubhai did not rule at the hearing, leaving unresolved how federal disability law applies to the state’s restrictions on where psilocybin services may be provided.
The lawsuit, as reported by oregonlive.com, asks whether licensed providers can administer psilocybin at the homes of people with disabilities or terminal illnesses who cannot get to a service center. Oregon law, adopted in 2020, allows administration under supervision inside licensed service centers, according to the report. Attorney Jordan C. Harris, representing two psilocybin providers suing the Oregon Health Authority, argued that the agency must make a reasonable accommodation under the Americans with Disabilities Act for patients unable to reach those centers.
Harris asked Kasubhai to require the health authority to allow home services, arguing that delivering one or possibly two doses to a patient would pose little risk of diversion. Alexander C. Jones, representing Oregon and the health authority, argued that state law bars administration outside licensed service centers and that the agency cannot change rules established through voter-approved Measure 109, which created Oregon’s regulated psilocybin services program.
The dispute over access and safeguards
Jones argued that home administration would change the program’s design, which he said aims to provide access while limiting diversion to children and others at risk. He pointed to service-center rules barring people under 21, 24-hour security cameras and strict storage requirements. Jones also argued that the providers lack standing because they have not identified specific homebound people seeking psilocybin. He said the state would follow any court order, though implementation details would need to be worked out.
The case stems from the health authority’s 2023 denial of separate requests by two licensed facilitators to provide psilocybin to homebound patients. The facilitators filed their federal lawsuit in June 2024, according to Lookout Eugene-Springfield. Kasubhai later denied the state’s motion to dismiss, and the plaintiffs subsequently asked the court to rule without a full trial.
The legal test before the court
At the hearing, Kasubhai described the competing obligations: the court must apply the federal ADA, while the health authority must follow state law. He said state law might need revision to permit a reasonable accommodation for home-based services. The federal Controlled Substances Act, which classifies psilocybin as a Schedule I drug and prohibits its manufacture, distribution, dispensing and possession outside specially registered research, adds another legal constraint.
Program use and the ADA standard
The Oregon Health Authority’s 2025 year-in-review reported 5,935 clients in the state’s psilocybin services program. It also recorded 13 emergency-services contacts, or 0.2% of clients, in 2025. The 2025 edition of Oregon Revised Statutes lists developing a long-term plan for safe, accessible and affordable psilocybin services for adults 21 and older among the law’s purposes. Under the federal Title II regulation, public entities must make necessary reasonable modifications to avoid disability discrimination unless they can demonstrate that a modification would fundamentally alter the service, program or activity, according to the Electronic Code of Federal Regulations.
The two outlets differed on the expected timing of a decision. OregonLive reported that Kasubhai would take the matter under consideration and issue an order in the near future; Lookout Eugene-Springfield reported that he said he would rule within about 60 days after considering the federal disability law at issue.
A hearing at the law school
More than 180 first-year law students attended the hearing at the University of Oregon School of Law, while other students and faculty watched a live video feed from an overflow room, according to the outlet’s account.
Kasubhai has taken the case under advisement. The ruling could affect whether disabled and terminally ill Oregonians can access the state’s regulated psilocybin services without traveling to a licensed center.









